Your institution may have access to this item. Find your institution then sign in to continue.
Title
Goserelin may reduce risk of early menopause in young women with breast cancer.
Abstract
The article reports that premenopausal women younger than 50 years of age who were assigned to receive chemotherapy plus goserelin showed no signed or symptoms of cancer and their overall survival at 4 years WAS 92% as compared to the 82% in the standard chemotherapy group.